west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "曲霉菌" 15 results
  • Detection of Invasive Aspergillosis by Serum Galactomannan Test: A Systematic Review

    Objective To assess the quality of current domestic literature about enzyme-linked immunosorbent assay (ELISA) for invasive aspergillosis diagnosis by detecting Aspergillus galactomannan (GM) antigen, and to analyze the sources of bias and variability, as well as the diagnostic ability of different thresholds. Methods Both computer-based online search and manual retrieval were employed to identify relevant articles. The statistical information and quality of science were assessed and classified. The data were analyzed using Meta Disc 1.4 software. The best cutoff value for defining a positive test result was selected by summarizing the following statistical indicators as sensitivity, specificity, likelihood ratio (LR) and summary receiver operating characteristic curve (SROC curve), and by calculating the area under the curve (AUC) as well. Results A total of 20 studies among 2658 literatures were included in accordance with the inclusion criteria, and were divided into different groups based on different cutoff values. Though heterogeneity tests showed no threshold effect, and there were other reasons of heterogeneity. So the data were analyzed by random effects model. The results showed that, compared with other groups, the one with cutoff value set at 0.7 (AUC=0.9456, Q= 0.884 6) showed the best accuracy in diagnosing. Conclusion ELISA detection of Aspergillus GM antigen with cutoff value set at 0.7 has important significance in the early diagnosis of invasive aspergillosis, and it can be conducive to reduce mortality in patients at high risk for Aspergillus infection.

    Release date:2016-09-07 11:07 Export PDF Favorites Scan
  • 侵袭性肺曲霉菌感染诊治进展

    随着社会老龄化, 抗肿瘤药物、免疫抑制剂和器官移植等治疗的广泛开展, 在危重患者中广谱抗生素药物的长期应用, 与之伴随的是真菌感染发生的逐年增多, 其中侵袭性曲霉菌感染因其感染隐匿, 难以诊治和高死亡率等特点被临床医生所重视。按我国医院感染监控网分析, 医院真菌感染率从1993 ~1996 年的13. 9% 上升至1998 ~1999 年的17. 1% 、1999 ~2000 年的24. 4% 。侵袭曲霉菌病特别是肺部曲霉菌感染多发生在有严重基础疾病的患者,预后差, 病死率达50% ~100% [ 1 ] 。本文回顾相关研究文献中关于侵袭性肺曲霉菌诊治进展, 高危人群, 目前诊断检测技术的临床价值, 抗曲霉菌药物特点和治疗现状。

    Release date:2016-08-30 11:56 Export PDF Favorites Scan
  • Role of aspergillus infection in bronchiectasis and its diagnosis and treatment

    Bronchiectasis is a heterogeneous disease characterized by abnormal expansion of the bronchi, manifested by cough, sputum, and recurring lung infections. As one of the common fungi of lung infection, aspergillus can not only appear as the outcome of the disease in bronchiectasis, but also as an inducement to participate in the disease progression, and ultimately complicate the course of bronchiectasis. This article describes the susceptibility factors and pathogenic mechanisms of aspergillus in bronchiectasis, and further introduces the diagnosis and treatment status of bronchiectasis combined with aspergillus infection, aiming to clarify the effect of aspergillus infection on bronchiectasis and provide new thinking directions for its clinical diagnosis and treatment.

    Release date:2022-02-24 02:27 Export PDF Favorites Scan
  • Effects of Aspergillus fumigatus spores on airway inflammation and airway responsiveness on asthmatic rat model

    Objective To explore the effects of Aspergillus fumigatus(A. fumigatus) spores on airway inflammation and responsiveness in asthmatic rats.Methods Seventy male Wistar rats were randomly divided into Ⅰ and Ⅱ groups(n=35 in each group),then Group Ⅰ and Group Ⅱ were subdivided into a normal control group(n=5),an asthma group(n=10),a spores-treated control group(n=10),and a spores-treated asthma group(n=10).The rats were sensitized to ovalbumin(OVA) and challenged with aerosol OVA to establish the asthma model.The effects of A. fumigatus spores on asthmatic rats before and after OVA aerosol challenging were investigated in Group Ⅰ and Group Ⅱ,respectively.The parameters associated with bronchial epithelial damage were observed by total protein concentration in BALF measured by BCA method.Total and differential cell counts in BALF were also counted.The airway resistance and airway responsiveness were calculated by transpulmonary pressure and gas flow rate.Results In Group Ⅰ,the total protein in BALF in the asthma group treated with A. fumigatus spores before OVA challenging(Group CA) was increased remarkably compared to the asthma group(Group A1)[(1.125±0.254)μg/mL vs(0.825±0.173)μg/mL,Plt;0.01].The nonspecific airway resistances induced by different concentration of acetylcholine in Group CA [(0.997±0.196)cm H2O•mL-1•s-1,(1.123±0.142)cm H2O•mL-1•s-1,(1.130±0.197)cm H2O•mL-1•s-1]were increased significantly compared to Group A1 [(0.655±0.089)cm H2O•mL-1•s-1,(0.687±0.048)cm H2O•mL-1•s-1,(0.821±0.043)cm H2O•mL-1•s-1](all Plt;0.05).In Group Ⅱ,however,the above parameters in the asthma group treated with A. fumigatus spores after OVA challenging(Group AC) were not dramatically increased compared with the asthma group(Group A2)(all Pgt;0.05).The differences in the total and differential cell counts in BALF in Group CA were not remarkable compared to other subgroups in Group Ⅰ(all Pgt;0.05).But the BALF neutrophil count in Group AC was increased obviously compared to Group A2 [(2.488±0.420)×106 vs (0.936±0.459)×106,Plt;0.05].Conclusion These data indicate that exposure to A. fumigatus spores before challenging causes aggravated epithelial damage and increased airway resistance in an asthma rat model.

    Release date:2016-08-30 11:35 Export PDF Favorites Scan
  • Diagnosis and Surgical Treatment of Pulmonary Tuberculosis Complicated by Aspergillus Infection

    Objective To investigate diagnosis and treatment strategies of patients with pulmonary tuberculosis (TB) complicated by Aspergillus infection. Methods Clinical data of 38 patients with pulmonary TB complicated by Aspergillus infection who underwent surgical treatment from January 2008 to December 2010 in Chengdu Infectious Disease Hospital were retrospectively analyzed. There were 23 male patients and 15 female patients with their average age of 37.8 (23-59) years. Preoperatively,all the patients received regular anti-TB treatment for more than 2 weeks,and patients with definite Aspergillus infection received anti-Aspergillus therapy for more than 3 days with consultation of infectious disease physicians. After above treatment,26 patients underwent lobectomy,1 patient underwent right pneumonectomy,and 11 patients underwent left pneumonectomy. All the patients were followed up at the outpatient department after discharge. They were evaluated every 2 weeks in the first 3 months,every 1 month after 3 months,and every 6 months after 1 year. During follow-up,they received acid-fast bacillus smear and sputum culture to check Aspergillus,as well as CT chest scan. Results All the patients successfully received surgical resection of the pulmonary lesion without perioperative death or severe complication. Postoperative pathology examination confirmed pulmonary TB with Aspergillosis infection in all the 38 patients,whose basic diseases included TB cavity in 17 patients,TB-destroyed lung in 12 patients,and post-TB bronchiectasis in 9 patients. All the patients were followed up after discharge for 1.5-4.5 years. During follow-up,they received regular anti-TB therapy for adequate duration in addition to antifungal medications such as voriconazole. None of the 38 patients had recurrence of Aspergillus infection or pulmonary TB. One patient had hemoptysis which was controlled after proper treatment during follow-up. Conclusion Missed diagnosis rate of pulmonary TB complicated by Aspergillus infection is high. Surgical resection of the pulmonary lesion and postoperative medication treatment are the most effective treatment strategies for patients with pulmonary TB complicated by Aspergillus infection.

    Release date:2016-08-30 05:46 Export PDF Favorites Scan
  • 侵袭性肺迟缓曲霉病一例报道

    目的 通过本病例及综述以提升对侵袭性肺迟缓曲霉病早期病原学诊断的重视,并为治疗方案提供参考依据。方法 回顾我科诊治的1例COVID-19感染后继发的侵袭性肺迟缓曲霉病患者的临床资料,复习既往文献总结分析肺迟缓曲霉病的临床表现、诊断及治疗用药方案。结果 患者79岁,老年男性,咳嗽、咳痰伴呼吸困难4月余。胸部CT提示:双肺数个结节灶,部分结节内空洞形成;散在实变影。G实验、GM结果阴性。气管镜肺泡灌洗液送检mNGS查见迟缓曲霉菌。给予伏立康唑治疗后效不佳,且继发肝功能异常,调整为艾沙康唑治疗后临床症状及肺部影像学征象好转。复习文献,共有12例个案报道,其中8例存在免疫抑制状态,4例合并慢性阻塞性肺病,6例为器官移植术后。临床选药以伏立康唑和两性霉素B居多,虽经治疗仍有66.7%(8例)患者在确诊后7周内死亡。结论 本例为国内外首次使用艾沙康唑成功治疗侵袭性肺迟缓曲霉病的报告。侵袭性肺迟缓曲霉病属于罕见病,免疫抑制状态是其高危因素。该病进展迅速,具有高度耐药性,预后差,病死率高,早期病原学诊断尤为关键。

    Release date: Export PDF Favorites Scan
  • 狼疮性肾炎合并肺部多重真菌感染一例

    Release date: Export PDF Favorites Scan
  • Clinicopathologic study on fungal necrcotizing retinochoroiditis

    Objective To investigate the clinical manifestation and histopathologic changes of the fungal necrotizing retinochoroiditis. Methods Collecting 7 cases of fungal retinochoroiditis with severe immunodepression and loss of visual acuity.Seven removed eyeballs were stained with HE,PAS and silver methenamine,and observed by light microscopy,and in addition,2 of them examined by electron microscopy.Also fungal cultures of blood and affected tissues were performed. Results The chief clinical macnifestation included ciliary injection of conjunctiva,opaque aqueous fluid and vitreous and diffuse hemorrhage and greyt white opacity with retinal detachment in severe cases.Pathologic changes included hemorrhage in the retina,chorioretinal tissue necrosis,hyphae in the blood vessels,affected tissue and vitreous.Fungal culture of blood was positive in three cases.Culture of affected tissues was positive in all cases. Conclusions Eedogenous fungal infection of choroid and retina may be due to the severe immunodepression of the sufferers and usually causes chorioretinal tissue destruction and blind. (Chin J Ocul Fundus Dis, 1999, 15: 235-237)

    Release date:2016-09-02 06:07 Export PDF Favorites Scan
  • 肺曲霉菌病的外科治疗

    目的探讨肺曲霉菌病的临床特点与外科治疗原则。方法回顾分析32例肺曲霉菌病患者的临床资料和手术治疗结果,手术施行采用标准后外侧切口肺叶切除术6例,楔形切除术3例,胸腔镜或胸腔镜辅助改良后外侧微创小切口楔形切除术15例,肺叶切除术6例,肺段切除术2例。结果21例无肺原发疾病,11例有肺原发疾病。痰菌检查阳性率为13.3%(2/15),术前诊断符合率为28.1%(9/32);术后并发症发生率为15.6%(5/32),其中切口皮下积液、肺膨胀不良各2例,气胸1例;随访32例,随访10~160个月,无咯血或血痰、肺曲霉菌病复发或播散。结论肺曲霉菌病多数无肺原发疾病和症状,无论有否症状均应手术治疗,而微创外科手术治疗并发症少且较轻,是首选的治疗方法。

    Release date:2016-08-30 06:26 Export PDF Favorites Scan
  • Clinical characteristics of patients with Coronavirus Disease 2019-associated pulmonary mucormycosis

    ObjectiveTo analyze the clinical characteristics, prognosis and predisposing factors of coronavirus disease 2019 (COVID-19) associated pulmonary mucormycosis (CAPM), so as to improve people's understanding of the disease.MethodsFrom from September 1, 2021 to July 31, 2024, 11 patients with CAPM who were hospitalized in Beijing Chaoyang Hospital affiliated to Capital Medical University were retrospectively collected, and 22 patients with non-CAPM were included after matching according to the ratio of 1:2. The clinical manifestations, laboratory examinations, imaging features, tracheoscopy, treatment and prognosis of the two groups were analyzed. ResultsThe average age of patients in CAPM group was 59.5 ± 10.6 years, with 81.8% of males; diabetes mellitus (90.9%) was the most common complication. In CAPM group, the median time after the occurrence of mucor after COVID-19 was 13.0 (10.0, 24.0) days. The utilization rate of glucocorticoids in the CAPM group was 63.6% (7/11), which was significantly higher than that in non-CAPM group [13.6% (3/22)], and the difference between the groups was statistically significant (P=0.006). The C-reactive protein level in CAPM group was significantly higher at 93.90 (75.00, 129.00) mg/L than that in non-CAPM group at 26.10 (4.83, 114.03) mg/L, with a statistically significant difference (P=0.040). The CD4+T lymphocyte counts and B lymphocyte counts in CAPM group were 223.00 (66.75, 336.75)/µL and 32.00 (21.75, 55.25)/µL, respectively, which were significantly lower than those in the non-CAPM group 394.00 (206.00, 610.00)/µL and 112.50 (56.00, 159.25)/µL, with statistical differences between the groups (P=0.040, P=0.040). In terms of imaging, the main imaging findings were the involvement of multiple lobes in both groups. 63.6% (7/11) of patients with pulmonary aspergillosis in CAPM group were significantly higher than those(4/22, 18.2%) in non-CAPM group (P=0.017). The incidence of dyspnea in CAPM group was significantly higher than that in non-CAPM group (90.9% vs. 50.0%, 0.027%).ConclusionThe proportion of glucocorticoid use and the proportion of pulmonary aspergillosis in CAPM group are significantly higher, and they are in a more serious state of immunosuppression. Once combined with pulmonary aspergillus , the mortality rate is higher.

    Release date: Export PDF Favorites Scan
2 pages Previous 1 2 Next

Format

Content